Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2003
09/04/2003US20030166559 Comprises tumor necrosis factor antagonist activity for treatment of autoimmune conditions
09/04/2003US20030166552 For removing viruses from samples (for protection against acquired immunodeficiency syndrome); contraceptives
09/04/2003US20030166546 Uses of THANK, a TNF homologue that activates apoptosis
09/04/2003US20030166543 Functional antagonists of hedgehog activity
09/04/2003US20030166540 Polynucleotide encoding a novel human G-protein coupled receptor, HGPRBMY30
09/04/2003US20030166539 Compositions and methods of use for a bombesin peptide
09/04/2003US20030166538 Isolated inflammation-related gene, the protein molecule encoded by the gene, and the use of the gene in diagnosis and treatment of inflammatory conditions.
09/04/2003US20030166536 Expression product of DNA encoding human or hybrid human/ mammalian factor VIII, said DNA comprising DNA encoding a modified A2 domain, the DNA having one or more nucleotide substitutions resulting in a coding change at one or more of
09/04/2003US20030166532 Annexin V, is used to prevent thrombosis without increasing hemorrhage. Annexin binds to phosphatidylserine on the outer surface of cell membranes, thereby preventing binding of the prothrombinase complex necessary for thrombus formation.
09/04/2003US20030166530 Conjugate heat shock protein-binding peptides
09/04/2003US20030166527 Granulocyte colony stimulating factor ("G-CSF") analog polypeptide compositions, related nucleic acids, expression constructs, host cells, and processes for recombinant production of the present G-CSF analogs.
09/04/2003US20030166526 Novel gene (designated 158P1H4) and its encoded protein are described. While 158P1H4 exhibits tissue specific expression in normal adult tissue, it is aberrantly expressed in multiple cancers including set forth in Table 1. Consequently, 158P1H4
09/04/2003US20030166522 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/04/2003US20030166521 Inhibition of thrombosis by treatment with P-selectin antagonists
09/04/2003US20030166512 Protein carrier system for therapeutic oligonucleotides
09/04/2003US20030166300 Growth-related inflammatory and immune response protein
09/04/2003US20030166288 Altering Ku80 levels in plants; recobinant expression cassettes
09/04/2003US20030166287 Gene therapy, drug delivery a virus-like particle for binding to a human transport protein; antitumor agents
09/04/2003US20030166286 Chimeric adenoviral fiber protein and methods of using same
09/04/2003US20030166285 Methods and compositions for genetically modifying primate bone marrow cells
09/04/2003US20030166284 Encoding hepatitis B virus surface antigen, treating hepatic diseases; inverted terminal repeats has the native D-sequences modified, some nucleotides are deleted or replaced; genetic engineering
09/04/2003US20030166283 Drug screening a modulator as antitumor agents, antiproliferative agents, as promoter providing neuronal cell growth, wound healing, and cerebral injury healing; genetic engineering, receptor binding assay, gene expression
09/04/2003US20030166282 Forming a double stranded RNAs, has a replication sequence that is identical to a selected target gene; gene therapy
09/04/2003US20030166281 Genetic transcription, cells comprising regulatory sequence, a reporter gene to express a signal peptide, protein biosynthesis; reducing neutrophils, expression of human growth hormone
09/04/2003US20030166279 Minicell-based transfection
09/04/2003US20030166277 Targeted vaccine delivery systems
09/04/2003US20030166275 Preparation of erythropoietin by endogenous gene activation
09/04/2003US20030166271 Supporting cell differentiation in culture with a genetical modified cells; use for gene therapy
09/04/2003US20030166268 An isolated polynucleotide encodes a polypeptide antibodies and antiidiotypic antibodies; treating cytokine-induced inflammation, inhibiting viral proliferation; antiproliferative agents, viricides
09/04/2003US20030166267 Method for improving genetic stability of foreign insert nucleotide sequence in recombinant single-stranded RNA virus
09/04/2003US20030166266 Open reading frame detection compositions and methods
09/04/2003US20030166258 Saccharomyces cerevisiae yeast strain with functional expression of a glut transporter
09/04/2003US20030166255 Culturing a host cell for expressing a first recombinant protein isoprenoid synthase and a second recombinant protein cytochromes, for transforming a disease resistance plants; genetic engineering
09/04/2003US20030166254 Moving promoter distal gene toward a wild-type 3' gene; gene mapping, genetic engineering; an attenuated virus useful for a vaccine
09/04/2003US20030166253 A simple and efficient method of producing mammalian reovirus is developed using HEK 293 cells. The method provides for fast production of reovirus in high yield. Furthermore, this method provides for a simpler purification procedure of the
09/04/2003US20030166252 Paramyxovirus-derived RNP
09/04/2003US20030166251 High efficiency retroviral vector which contains genetically engineered cellular non-coding sequence harboring splicing acceptor
09/04/2003US20030166248 Proteases from gram-positive organisms
09/04/2003US20030166247 Transforming growth factor binding proteins; fusion proteins; knockout animal models; for treatment of osteoporosis/ fractures
09/04/2003US20030166246 Human aspartic proteases
09/04/2003US20030166245 For preparing reagents for use in detecting molecules which affect formation of actin cytoskeleton; drug screening
09/04/2003US20030166241 Tryptophan translases; for production of herbicides
09/04/2003US20030166240 DNA & protein binding miniature proteins
09/04/2003US20030166239 Bone morphogenic proteins; for regulating bone homeostasis, adiposity, and calcification of atherosclerotic plaques
09/04/2003US20030166238 Recombinant toxin fragments
09/04/2003US20030166236 Obtained from Trichoderma; high temperature/ph production; papermaking/bleaching
09/04/2003US20030166235 Enzyme inhibitors; immunoassay
09/04/2003US20030166234 A METHOD FOR PREPARING MASSIVELY RmlC PROTEIN AND PURIFIED RmlC PROTEIN OF MYCOBACTERIUM TUBERCULOSIS BY IT
09/04/2003US20030166232 PARG, a GTPase activating protein which interacts with PTPL1
09/04/2003US20030166231 Novel human RNA-binding protein
09/04/2003US20030166229 Human POSH-like protein 1
09/04/2003US20030166228 Anti-interferon-alpha antibodies
09/04/2003US20030166227 Comprises polypeptides having exonuclease domains in plants; homologous recombination
09/04/2003US20030166224 18232, a novel dual specificity phosphatase and uses therefor
09/04/2003US20030166221 Megakaryocyte tyrosine kinases; signal transduction in hematopoietic cells
09/04/2003US20030166219 Mitogen-activated protein/extracellular signal-regulated kinases (MAP/ERK)
09/04/2003US20030166218 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
09/04/2003US20030166217 For detecting migrating or metastasizing cells; antimitotic; homologous recombination
09/04/2003US20030166212 Alpha1,3-fucosyltransferase
09/04/2003US20030166211 Alpha-1,3 fucosyltransferases and expression systems for making and expressing them
09/04/2003US20030166210 Polypeptide and DNA (RNA) encoding such polypeptide and a procedure for producing such polypeptide by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polypeptide for the treatment of cognitive and
09/04/2003US20030166208 Having poly-N-acetyllactosamine sugar chains synthesis-related activity; use in antiinflammation, antiinfection, inhibition of cancer metastasis
09/04/2003US20030166207 Nucleic acid and amino acid sequences for acetolactate synthase, acetolactate synthase regulatory regions, alpha-tubulin promoter, a promoter from a Thraustochytriales polyketide synthase system, and fatty acid desaturase promoter
09/04/2003US20030166206 Method for cloning and expression of mspa1i restriction endonuclease and mspa1i methylase in e. coli
09/04/2003US20030166205 Plant regulatory sequences
09/04/2003US20030166202 P450 Monooxygenases of the cyp79 family
09/04/2003US20030166198 Antibodies to mitogenic oxygenases
09/04/2003US20030166197 Isolated polynucleotide of given sequence encoding a EIN6 protein; transforming cell to desired phenotype
09/04/2003US20030166196 Fusion proteins and polynucleotides encoding gelonin sequences
09/04/2003US20030166194 Of given sequence; genetic mapping; anticoagulants
09/04/2003US20030166191 Promoter-regulatory gene operons which repress transcription; use for regulating gene expression in a cell
09/04/2003US20030166190 Nucleic acids related to plant retroelements
09/04/2003US20030166189 Peptide of given amino acid sequence; sulfotransferases; useful in labeling agents with tagged sulfur, diagnosis/treatment of cancer, hypertension, renal and neurodegenerative diseases
09/04/2003US20030166187 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
09/04/2003US20030166185 Amino acid sequences of peptides that are encoded by genes within the human genome, the enzyme peptides of the present invention. The present invention specifically provides isolated peptide and nucleic acid molecules, methods of
09/04/2003US20030166181 Controlled electroporation and mass transfer across cell membranes
09/04/2003US20030166179 Methods and materials for the synthesis of organic products
09/04/2003US20030166175 Process for clavulanic acid production
09/04/2003US20030166174 Fermenting amino acids using lysine resistant methanobacterium for animal feeds, foodstuffs and drug design
09/04/2003US20030166171 Genes encoding exopolysaccharide production
09/04/2003US20030166170 Propagating damaged nucleotide sequences using bacterial polymerases
09/04/2003US20030166169 Preparing RNA viral nucleotide sequences in vitro; high throughput assay; in vitro transcription
09/04/2003US20030166167 Adenoviral library assay for E2F regulatory genes and methods and compositions for screening compounds
09/04/2003US20030166166 Deregulation of glutamine PRPP amidotransferase activity
09/04/2003US20030166165 Comprises nucleotide sequences coding polyene macrolide antibiotics for use in veterinary medicine
09/04/2003US20030166164 IL-17 like molecules and uses thereof
09/04/2003US20030166162 Preparing genetically engineered polypeptides/zymogens for pharmaceutical or food composition
09/04/2003US20030166158 NTR3, a novel member of the TNF-receptor supergene family
09/04/2003US20030166157 Genetically engineered plasmid for preparing bovine growth hormone in escherichia
09/04/2003US20030166155 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/04/2003US20030166154 Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof
09/04/2003US20030166153 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/04/2003US20030166151 Comprises peptides of ionotropic glutamate receptor for diagnosing and treating nervous system disorders; drug screening
09/04/2003US20030166150 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
09/04/2003US20030166143 Genetically engineered cell coding G protein coupled formyl peptide orphan receptor (FPRL-1) for monitoring adjustment in chemotaxis and cell respiratory activity; drug screening
09/04/2003US20030166141 Regulation of endogenous gene expression in cells using zinc finger proteins
09/04/2003US20030166140 Expression vector wherein said expression vector comprises a polynucleotide promoter sequence, a polynucleotide encoding a signal sequence, a polynucleotide encoding an antigen protein or peptide, a polynucleotide polyadenylation sequence all
09/04/2003US20030166137 Mammalian sweet and amino acid heterodimeric taste receptors
09/04/2003US20030166136 Comprises polypeptide coding c-type lectin (CTL-1) for diagnosing, preventing or treating tumors; antiproliferative agents
09/04/2003US20030166132 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
1 ... 2432 2433 2434 2435 2436 2437 2438 2439 2440 2441 2442 2443 2444 2445 2446 2447 2448 2449 2450 2451 2452 ... 4023